All Stories

  1. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

    Article • Expert Opinion on Investigational Drugs, April 2019, Taylor & Francis

    Dr Paolo Bossi, Dr Salvatore Alfieri

  2. Prevalence of Fatigue in Head and Neck Cancer Survivors

    Article • Annals of Otology Rhinology & Laryngology, January 2019, SAGE Publications

    Dr Paolo Bossi

  3. Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

    Article • Disease Markers, January 2017, Hindawi Publishing Corporation

    Dr Paolo Bossi

  4. Safety of Combination Treatment with Imatinib Mesylate, Carboplatin, and Cetuximab in a Patient with Multiple Cancers: A Case Report

    Article • Tumori Journal, November 2016, SAGE Publications

    Dr Paolo Bossi

  5. Thyroidectomy and Neck Exploration: New Surgical Approaches

    Article • April 2016, Taylor & Francis

    Dr Paolo Bossi

  6. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer

    Article • Oral Oncology, September 2014, Elsevier

    Dr Paolo Bossi

  7. Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse: Table 1

    Article • Pain Medicine, May 2014, Oxford University Press (OUP)

    Dr Paolo Bossi

  8. Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy

    Article • Cancer Biology & Therapy, March 2014, Taylor & Francis

    Dr Paolo Bossi

  9. Prevention and treatment of oral mucositis in patients with head and neck cancer treated with (chemo) radiation: report of an Italian survey

    Article • Supportive Care in Cancer, February 2014, Springer Science + Business Media

    Dr Paolo Bossi, Dr Elvio G. Russi

  10. Emerging tyrosine kinase inhibitors for head and neck cancer

    Article • Expert Opinion on Emerging Drugs, October 2013, Informa Healthcare

    Dr Paolo Bossi

  11. Comments on “Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure” by Chan and Coll

    Article • Oral Oncology, October 2013, Elsevier

    Dr Paolo Bossi

  12. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients

    Article • Supportive Care in Cancer, July 2013, Springer Science + Business Media

    Dr Paolo Bossi

  13. Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis

    Article • Supportive Care in Cancer, May 2013, Springer Science + Business Media

    Dr Paolo Bossi

  14. Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma

    Article • Oral Oncology, May 2013, Elsevier

    Dr Paolo Bossi

  15. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma

    Article • Future Oncology, January 2013, Future Medicine

    Dr Paolo Bossi

  16. Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma

    Article • Journal of the American Academy of Dermatology, November 2012, Elsevier

    Dr Paolo Bossi

  17. Safety and feasibility of every‐other‐week maintenance cetuximab after first‐line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer

    Article • Head & Neck, October 2012, Wiley

    Dr Paolo Bossi

  18. Thyroid Cancer

    Article • January 2012, Springer Science + Business Media

    Dr Paolo Bossi

  19. Isolating p16-positive/HPV-negative Oropharyngeal Cancer

    Article • The American Journal of Surgical Pathology, May 2011, Wolters Kluwer Health

    Dr Paolo Bossi

  20. Carcinoma del rinofaringe

    Article • January 2011, Springer Science + Business Media

    Dr Paolo Bossi

  21. Carcinomi dei seni paranasali e delle fosse nasali

    Article • January 2011, Springer Science + Business Media

    Dr Paolo Bossi

  22. Comment on “Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis”, by Rades et coll.

    Article • Oral Oncology, December 2010, Elsevier

    Dr Paolo Bossi

  23. Oropharyngeal Squamous Cell Carcinoma Treated With Radiotherapy or Radiochemotherapy: Prognostic Role of TP53 and HPV Status

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2009, Elsevier

    Dr Paolo Bossi

  24. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

    Article • Oral Oncology, November 2009, Elsevier

    Dr Paolo Bossi

  25. Further Improvement in Outcomes of Nasopharyngeal Carcinoma With Optimized Radiotherapy and Induction Plus Concomitant Chemotherapy: An Update of the Milan Experience

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2009, Elsevier

    Dr Paolo Bossi

  26. Fragile Histidine Triad Gene Inactivation in Lung Cancer

    Article • American Journal of Respiratory and Critical Care Medicine, March 2009, American Thoracic Society

    Dr Paolo Bossi

  27. Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

    Article • Annals of Oncology, September 2008, Oxford University Press (OUP)

    Dr Paolo Bossi

  28. Folate in Head and Neck Squamous Cell Cancer Chemoprevention: Purposely Left Out?

    Article • Journal of Clinical Oncology, July 2008, American Society of Clinical Oncology (ASCO)

    Dr Paolo Bossi

  29. Biological agents in head and neck cancer

    Article • Expert Review of Anticancer Therapy, November 2007, Taylor & Francis

    Dr Paolo Bossi

  30. Biological agents in head and neck cancer

    Article • Annals of Oncology, September 2006, Oxford University Press (OUP)

    Dr Paolo Bossi

  31. A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?

    Article • Current Opinion in Oncology, May 2006, Wolters Kluwer Health

    Dr Paolo Bossi

  32. Advances in the changing patterns of aetiology of head and neck cancers

    Article • Current Opinion in Otolaryngology & Head & Neck Surgery, April 2006, Wolters Kluwer Health

    Dr Paolo Bossi

  33. Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas?

    Article • Oral Oncology Extra, October 2005, Elsevier

    Dr Paolo Bossi

  34. Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland

    Article • Oral Oncology, October 2005, Elsevier

    Dr Paolo Bossi

  35. Head and neck tumors other than squamous cell carcinoma

    Article • Current Opinion in Oncology, May 2004, Wolters Kluwer Health

    Dr Paolo Bossi